Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05905835 · ClinicalTrials.gov registry record · NA
Treatment of PAF With the Synaptic System
A NA study of Paroxysmal Atrial Fibrillation, sponsored by Synaptic Medical Corporation.
- Active
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 10
- Study locations
NCT05905835 is a NA study of Paroxysmal Atrial Fibrillation that is active but no longer recruiting, run by Synaptic Medical Corporation. The registered enrollment target is 128 participants, below the 854-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (85% lower). The trial reports 10 study locations across 8 states.
The verdict
NCT05905835, a NA study of Paroxysmal Atrial Fibrillation, is active but no longer recruiting, sponsored by Synaptic Medical Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 10
- Study locations
Study Summary
Enrolled subjects will be treated with the Synaptic Cryoablation System. Treatment will include cryoablation of the pulmonary veins to achieve PVI. All subjects will be followed for twelve (12) months after completion of the index ablation procedure.
Conditions Studied
Interventions
- DEVICE Synaptic Cryoablation System
Study Locations (10)
Arizona
- Banner University Medical Center - Phoenix
- Dignity Health Arizona Research Enterprise - Phoenix
California
- Cedars-Sinai Medical Center - Los Angeles
- Mercy General Hospital - Sacramento
Arkansas
- St. Bernard's Heart & Vascular - Jonesboro
Missouri
- St. Luke's Mid America - Kansas City
New York
- Northwell Health - Lenox Hill Hospital - New York
Tennessee
- Vanderbilt University Medical Center - Nashville
Texas
- Christus Health Frances Hospital - Tyler
Virginia
- VCU Pauley Heart Center - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2023-09-20 |
| Est. Completion | 2025-12-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05905835
The ClinicalTrials.gov registry entry for NCT05905835 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 854-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (85% lower). The listed sponsor is Synaptic Medical Corporation, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Paroxysmal Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Synaptic Cryoablation System is the first listed.
NCT05905835 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Arizona, California, Arkansas.
Frequently Asked Questions
What is clinical trial NCT05905835 about?
NCT05905835 is a clinical study titled "Treatment of PAF With the Synaptic System". Enrolled subjects will be treated with the Synaptic Cryoablation System. Treatment will include cryoablation of the pulmonary veins to achieve PVI. All subjects will be followed for twelve (12) months after completion of the index ablation procedure.
What is the current status of trial NCT05905835?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2023-09-20. Estimated completion is 2025-12-05.
What conditions does trial NCT05905835 study?
This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation.
What interventions are being tested in trial NCT05905835?
The interventions under investigation include: Synaptic Cryoablation System (DEVICE).
Who is sponsoring clinical trial NCT05905835?
This trial is sponsored by Synaptic Medical Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05905835 being conducted?
This trial has 10 study locations across Arizona, Arkansas, California, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
RECRUITING · NA
-
POLARx Post Approval Study (POLARx PAS)
RECRUITING · NA
-
Meditation and Education That is Nurse Delivered for Symptom Management in Paroxysmal Atrial Fibrillation (PAF)
ACTIVE NOT RECRUITING · NA
-
Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
ACTIVE NOT RECRUITING · NA
-
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.